Raptor Pharm (NASDAQ: RPTP) reported Q3 EPS of ($0.20), may not compare to the analyst estimate of ($0.16).

2014 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE